September 26, 2008
Cancer Research Institute Receives Charity Navigator’s Highest Rating
Charity Navigator, America’s premier independent charity evaluator, has awarded the Cancer Research Institute its highest rating, four out of four stars, placing it among the top organizations out of more than 5,300 of America’s largest charities. According to the watchdog’s Web site, the organization rates charities by evaluating two broad areas of financial health: their organizational efficiency and their organizational capacity. Ratings show givers how efficiently Charity Navigator believes a charity will use their support today, and to what extent the charity is growing its programs and services over time. Donors increasingly look to services like Charity Navigator to help them make intelligent giving decisions, and earning high scores has proven to have a positive impact on directing new donors to CRI.
In a statement from Charity Navigator, the watchdog, “salutes [CRI’s] charitable efforts. Receiving four out of a possible four stars indicates that [CRI] excels, as compared to other charities in America, in successfully managing [its] finances…in an efficient and effective manner. This rise in [CRI’s] rating is an exceptional feat, especially given the economic challenges many charities have had to face in the last year.”
“The Institute is proud to display Charity Navigator’s 4-star designation banner,” executive director Dr. Jill O’Donnell-Tormey states. “As donors must face increasingly difficult choices in selecting which charities to support in these challenging economic times, we hope this and our other designations of outstanding financial responsibility will assure donors that CRI is a trustworthy and efficient organization with a track-record of spending wisely and maximizing donor impact in conquering cancer.”
The Institute also currently holds an “A” rating from the American Institute of Philanthropy, meets the Better Business Bureau’s Standards for Charitable Accountability and is a BBB Wise Giving Alliance Charity Seal Holder, and has been named a “top 100 charity” by GiveSpot.com.
For more information about the Institute’s excellent charity ratings, go to: http://www.cancerresearch.org/ratings.html.
Contact: Brian Brewer, Director of Communications, Cancer Research Institute
(212) 688-7515 or bbrewer@cancerresearch.org
About the Cancer Research Institute
Since its inception in 1953, the Cancer Research Institute (CRI) has had a singular mission—to support and coordinate laboratory and clinical research that will yield an understanding of the immune system and its response to cancer, with the ultimate goal of developing immunological methods for the treatment, control, and prevention of the disease. To accomplish these goals, CRI supports scientists at all stages of their careers and funds every step of the research process, from basic laboratory studies to clinical trials testing novel immunotherapies. Guided by a Scientific Advisory Council, which includes five Nobel Prize winners and 30 members of the National Academy of Sciences, CRI awards fellowships and grants to scientists around the world. Through its Cancer Vaccine Collaborative, a joint program with the Ludwig Institute for Cancer Research, and its Coordinated Cancer Initiatives, the Institute is advancing preclinical and clinical research by serving as the integrating force and facilitator of collaborations among leading experts. CRI has thus become a catalyst for accelerating the development of cancer vaccines and antibody therapies that are providing new hope to cancer patients.
The Cancer Research Institute has one of the lowest overhead expense ratios among non-profit organizations, with the majority of its resources going directly to the support of its science, medical, and research programs. The Institute has earned a 4-star designation from Charity Navigator, is rated “grade A” by the American Institute of Philanthropy, is a GiveSpot.com Top 100 charity, and bears the seal of excellence from the Better Business Bureau Wise Giving Alliance.
For more information, visit http://www.cancerresearch.org.
# # #